1. Capizzi RL, Powell BL (1987) Sequential high dose ara-C and asparaginase versus high dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias. Semin Oncol 14 [Suppl 1]:40
2. Capizzi RL, Papirmeister B, Mullins JM, Cheng E (1974) The detection of chemical mutagens using the L5178Y/asn murine leukemia in vitro and in a host-mediated assay. Cancer Res 34:3073
3. Capizzi RL, Yang JL, Cheng E, Bjornsson T, Sahasrabudhe D, Tan RS, Cheng YC (1983) Alteration of the pharmacokinetics of high-dose ara-C by its metabolite, high ara-U, in patients with acute leukemia. J Clin Oncol 1:763
4. Capizzi RL, Oliver L, Friedman H, Davis R, Mayer R, Schiffer C, Lunghofer B, Royer G, Van Echo DA (1988) Variations in ara-C plasma concentration at steady-state during remission induction and intensification therapy of AML. A population pharmacokinetic study by CALGB. Proc Am Soc Clin Oncol 7:57
5. Eriksson S, Thelander L, Akerman M (1979) Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry 18:2948